Matthew J. Frigault, MD, MS, discussed what a community oncologist should know about the ongoing FDA investigation of chimeric antigen receptor T-cell therapies.
Matthew J. Frigault, MD, MS
Matthew Frigault, MD, MS, is the administrative director of the cellular therapy service at Massachusetts General Hospital and an assistant professor of medicine at Harvard Medical School in Boston, MD.
Articles by Matthew J. Frigault, MD, MS